Latest News and Press Releases
Want to stay updated on the latest news?
-
Dr. Frankel brings extensive knowledge and deep expertise that bridges advanced physics and quantum technologies New York, NY, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Q/C Technologies, Inc. (Nasdaq:...
-
ATLANTA, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Boys & Girls Clubs of America today announced a two-year partnership with Gilead Foundation to strengthen access to high-quality programming that...
-
Heat-Line announces next-generation leadership with Matthew Roberts as President, Brent Heise VP of Sales & Technology, and Laura Roberts VP of Quality.
-
HANOVER, Md, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...
-
Hong Kong, Jan. 03, 2025 (GLOBE NEWSWIRE) -- SOLOWIN HOLDINGS (Nasdaq: SWIN) (“SOLOWIN” or the “Company”), a leading financial services firm providing high-net-worth and institutional investors with...
-
Chicago, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Entara, a security-first eXtended Service Provider, was recently named to the Channel Futures 2024 Next Generation list recognizing fast-growing managed...
-
New York, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Overview The Global Next Generation Cancer Diagnostics Market size is expected to reach USD 19.1 billion by 2024. It is further anticipated to reach a...
-
Phase 2 trial with NGC-Cap in breast cancer underway NGC-Cap Phase 1b trial demonstrated a favorable safety profile with preliminary anti-tumor activity Preclinical studies demonstrated NGC-Iri...
-
Mr. David Pruner elaborates on preparing students and future entrepreneurs to solve dual issues of finding more energy for the world and at the same time lowering carbon intensity SANTA CLARITA,...
-
HANOVER, MD, March 25, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...